Executive Director, Cell Therapy Global Supply Chain Planning

The affected decision is how cell-therapy capacity, inventory and supply commitments are balanced across a global network. Value requires reliable patient-demand signals, qualified capacity data and explicit allocation rules; the principal failure mode is optimizing aggregate supply while missing product- and site-specific constraints.